Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals

• Published in: Annals of internal medicine Vol. 148; no. 6; p. 409
• Main Authors: Robicsek, Ari, Beaumont, Jennifer L, Paule, Suzanne M, Hacek, Donna M, Thomson, Jr, Richard B, Kaul, Karen L, King, Peggy, Peterson, Lance R
• Format: Journal Article
• Language: English
• Published: United States 18.03.2008
• Subjects: Anti-Bacterial Agents - therapeutic use; Chlorhexidine - therapeutic use; Cross Infection - epidemiology; Disinfectants - therapeutic use; Humans; Infection Control - methods; Intensive Care Units - statistics & numerical data; Methicillin Resistance; Mupirocin - therapeutic use; Patient Admission - statistics & numerical data; Poisson Distribution; Polymerase Chain Reaction; Population Surveillance - methods; Prevalence; Sensitivity and Specificity; Staphylococcal Infections - drug therapy; Staphylococcal Infections - epidemiology; Staphylococcal Infections - prevention & control; Staphylococcus aureus; United States - epidemiology; Universal Precautions - methods; United States

The effect of large-scale expanded surveillance for methicillin-resistant Staphylococcus aureus (MRSA) on health care-associated MRSA disease is not known. To examine the effect of 2 expanded surveillance interventions on MRSA disease. Observational study comparing rates of MRSA clinical disease dur...